Form 4: Analog Devices CEO Vincent Roche Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4


CEO Vincent Roche exercised stock options and sold shares of Analog Devices (ADI) on April 1, 2025, while also satisfying tax obligations through share withholding.

Summary

  • On March 31, 2025, Analog Devices CEO Vincent Roche had 18,315.949 shares withheld to cover tax obligations related to the vesting of 37,882 performance-based restricted stock units.
  • On April 1, 2025, Roche exercised options to acquire 10,000 shares of Analog Devices stock at a price of $94.41 per share.
  • Also on April 1, 2025, Roche sold 10,000 shares at a price of $200.26 per share under a pre-arranged 10b5-1 trading plan.
  • Following these transactions, Roche directly owns 107,912.256 shares of Analog Devices stock.
  • Roche also indirectly owns 34,828 shares through the Vincent Roche 2023 Grantor Retained Annuity Trust and 43,515 shares through the Vincent Roche 2024 Grantor Retained Annuity Trust.
  • After the transaction, Roche directly holds 114,637 non-qualified stock options.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The transactions themselves don't necessarily indicate positive or negative sentiment about the company's future prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, often driven by personal financial planning or diversification strategies. The use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

  • Executive compensation practices, including stock options and restricted stock units, are standard across the semiconductor industry.
  • Companies like Texas Instruments (TXN) and Qualcomm (QCOM) also utilize similar equity-based compensation plans for their executives.
  • The vesting schedules and exercise prices of these options are typically benchmarked against industry peers to attract and retain top talent.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the signal from insider selling.
  • Employees may be affected by the vesting of performance-based restricted stock units, which can impact morale and retention.

Key Dates

DateDescription
03/15/2021Date the non-qualified stock option became exercisable.
08/25/2023Date of the Vincent Roche 2023 Grantor Retained Annuity Trust.
03/01/2024Date the Reporting Person adopted a 10b5-1 plan.
10/03/2024Date of the Vincent Roche 2024 Grantor Retained Annuity Trust.
03/31/2025Date of tax withholding for vested restricted stock units.
04/01/2025Date of stock option exercise and share sale.
04/02/2025Date of the Form 4 filing.
03/11/2030Expiration date of the non-qualified stock option.

Keywords

Analog Devices, ADI, Vincent Roche, Stock Options, Share Sale, Form 4, Insider Trading, 10b5-1 Plan, Grantor Retained Annuity Trust, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.